FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the field of medicine, specifically to a pharmaceutical composition for stimulating the regeneration of epithelial and / or connective tissues comprising an effective amount of a compound of formula (I) (Treamid):
or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. Preferably, the tissue is selected from testicular tissue and prostate tissue.
EFFECT: invention widens the range of agents which stimulate the regeneration of epithelial and / or connective tissues, in particular testicular tissue and prostate tissue, which leads to the normalisation of diminished male fertility.
1 cl, 8 ex, 22 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
| USE OF PHARMACEUTICAL COMPOSITION OF β-CYCLODEXTRIN WITH 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE FOR INCREASING/RESTORING LIBIDO | 2019 |
|
RU2782133C2 |
| STIMULATOR OF REPARATIVE REGENERATION PROCESSES OF TESTICULAR TISSUE | 2019 |
|
RU2778238C2 |
| USE OF COMPLEX OF 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH β-CYCLODEXTRIN FOR CORRECTION OF SPERMATOGENESIS DISORDERS CAUSED BY CYTOTOXIC EFFECT | 2019 |
|
RU2782758C2 |
| METHOD FOR CORRECTION OF REMOTE CONSEQUENCES OF SPERMATOGENESIS CAUSED BY CYTOSTATIC EXPOSURE | 2013 |
|
RU2535002C2 |
| USE OF COMPLEX OF 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH β-CYCLODEXTRIN FOR TREATMENT OF PATHOZOOSPERMIA | 2019 |
|
RU2782140C2 |
| REMEDY FOR DELAYED EFFECTS OF SPERMATOGENESIS DISORDERS CAUSED BY CYTOSTATIC EFFECT | 2019 |
|
RU2717240C1 |
| METHOD OF CORRECTING, CAUSED BY CYTOSTATIC IMPACT | 2009 |
|
RU2406527C1 |
| METHOD FOR SIMULATION OF HYPOGONADISM CAUSED BY METABOLIC DISORDERS | 2016 |
|
RU2611936C1 |
| METHOD OF STIMULATION OF IMPAIRED SPERMATOGENESIS AND SYNTHESIS OF TESTOSTERONE USING TRANSPLANTATION OF THE NEONATAL TESTICULAR TISSUE | 2017 |
|
RU2669027C1 |
